You are adding an alert for:
Electrophysiological and morphological evaluation during 18 months follow-up of two regimens using Aflibercept for neovascular age-related macular degeneration (nAMD).
You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
The alert will be sent to: